Duo Oncology
Duo Oncology is a startup headquartered in Pittsburgh, United States, founded in 2020. It has raised at least $1.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Duo Oncology has raised at least $1.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Duo Oncology sits inside the Pittsburgh R&D ecosystem in the Global R&D Labs Directory.
Other startups in Pittsburgh
- 1486 Labs
- Aethl Bio
- Diamond Kinetics
- EfficientAI
- Garden Club Penn
- Gray Swan Security
- Lovelace AI
- Mine Vision Holdings
- NovoLINC
- PointsVille
- Respair
Related
- Innovation profile of Pittsburgh
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Duo Oncology do?
Duo Oncology is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Duo Oncology raised?
At least $1.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Duo Oncology based?
Duo Oncology is headquartered in Pittsburgh, United States.
When was Duo Oncology founded?
Duo Oncology was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.